SCHEMBL2900922

SCHEMBL2900922

Cc1ccc(C(=O)N(C)c2cccnc2)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.60
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
TSHR P16473 1/20 0.50
TRPV1 Q8NER1 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
GAA P10253 2/20 0.48
MAPK1 P28482 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
AGTR1 P30556 2/20 0.47
POLB P06746 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13096189 0.86 TRPV1 (0.47) MAPTALDH1A1SMN1; SMN2TRPV1MEN1
SCHEMBL12978300 0.85 ALDH1A1 (0.56) MAPTALDH1A1TSHRTRPV1MEN1
SCHEMBL13095766 0.83 TRPV1 (0.56) MAPTALDH1A1SMN1; SMN2TRPV1MEN1
SCHEMBL7370263 0.81 TRPV1 (0.57) MAPTALDH1A1SMN1; SMN2TRPV1KMT2A
SCHEMBL2897595 0.80 TRPV1 (0.53) MAPTSMN1; SMN2TRPV1KMT2AKDM4E
SCHEMBL9002118 0.79 MAPT (0.66) MAPTALDH1A1SMN1; SMN2TSHRCES2
SCHEMBL13163085 0.78 KMT2A (0.54) MAPTALDH1A1SMN1; SMN2TRPV1KMT2A
SCHEMBL12978312 0.77 TRPV1 (0.50) MAPTSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL5914014 0.76 TSHR (0.68) MAPTALDH1A1SMN1; SMN2TSHRCES2
SCHEMBL13095759 0.76 TRPV1 (0.47) ALDH1A1TRPV1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides BAYER CROPSCIENCE AG (DE) 2010-12-02 US disclosed
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides BAYER CROPSCIENCE AG (DE) 2010-12-02 US disclosed
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides BAYER CROPSCIENCE AG (DE) 2010-12-02 US disclosed
EP-2236505-A1 Acylated aminopyridines and pyridazines as insecticides Bayer CropScience AG (DE) 2010-10-06 EP disclosed
EP-2236505-A1 Acylated aminopyridines and pyridazines as insecticides Bayer CropScience AG (DE) 2010-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides AAAS, DDT, QDPR MAPT 3480/4885ALDH1A1 551/4885SMN1; SMN2 2519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.